ArticleCureus2025
Impact of Socioeconomic Deprivation on Access to Diabetes Technology in Children With Type 1 Diabetes Mellitus.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims The aim of this study was to assess the impact of socioeconomic deprivation on access to diabetes technology, specifically insulin pumps, and its outcome in children with type 1 diabetes. Methods This was a retrospective, observational, single-centre study of patients attending the paediatric unit at Basildon University Hospital, Basildon, United Kingdom. The study included all patients actively receiving diabetic care as of April 2023, including those with access to insulin pumps between January 2012 and April 2023, with their HbA1c values assessed before and after initiating insulin pump treatment. Deprivation quintiles were calculated. Statistical significance was calculated via chi-square tests, one-way ANOVA, and logistic regression approximation analysis. Results Included in the study were 243 children and young people (CYP) with a mean age of 13 years, 117 of whom were male (48%). Of this caseload, 48 had active access to insulin pumps with a mean deprivation quintile of 3.15 (SD 1.44). Quintile 1 identified the most deprived populations, and quintile 5, the least deprived. The insulin pumps were most accessible for CYP in the least deprived quintile compared to those in the most deprived quintile (31% vs. 10%; p<0.01). Within the caseload, following initiation of treatment, CYP in the most deprived quintile had the highest mean HbA1c values compared to the lowest values in the least deprived quintile (67.83 (SD 24.72) vs. 51.64 (SD 9.45); p=0.027). HbA1c outcomes were available for 35 CYP using pumps, with no statistically significant link to deprivation (p=0.348). CYP of White ethnicity had the highest use of insulin pumps compared to any other ethnicity (88% vs. 12%, p<0.0001). Conclusions Inequalities in access to diabetic technology still exist, with CYP in the least deprived quintile and those of White ethnicity experiencing greater access to technology. CYP from all deprivation quintiles experienced positive glycaemic control with technology use, suggesting improving access to technology may reduce glycaemic disparities in deprived populations. The most deprived populations might be disadvantaged due to their lack of exposure and awareness about newer technologies and advancements in diabetes care, as well as sub-optimal engagement with diabetes services, which is often seen in these cases. Further research is yet required to address these health inequalities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.